Bellicum investor alert: faruqi & faruqi, llp encourages investors
who suffered losses exceeding $50,000 investing in bellicum
pharmaceuticals, inc. to contact the firm
New york--(business wire)--faruqi & faruqi, llp, a leading national securities law firm, is investigating potential claims against bellicum pharmaceuticals, inc. (“bellicum” or the “company”) (nasdaq:blcm). aftermarket on january 30, 2018, bellicum issued a press release entitled “bellicum pharmaceuticals announces clinical hold on bpx-501 clinical trials in the united states[.]” therein, the company announced that it had “received notice from the u.s. food and drug administration (fda) that u.s. studies of bpx-501 have been placed on a clinical hold following three cases of encephalopathy deemed as possibly related to bpx-501.” bpx-501 is the company’s lead clinical product candidate designed to improve outcomes for patients undergoing stem cell transplant who lack a matched donor. on this news, the company’s share price fell from $8.20 per share on january 30, 2018 to a closing price of $6.08 on january 31, 2018—a $2.12 or a 25.85% drop. if you invested in bellicum stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/blcm. there is no cost or obligation to you. you can also contact us by calling richard gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. attorney advertising. the law firm responsible for this advertisement is faruqi & faruqi, llp (www.faruqilaw.com). prior results do not guarantee or predict a similar outcome with respect to any future matter. we welcome the opportunity to discuss your particular case. all communications will be treated in a confidential manner.
BLCM Ratings Summary
BLCM Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission